Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Bone. 2019 Apr 4;126:18–26. doi: 10.1016/j.bone.2019.03.032

Table 1.

Proteomic study purposes and design choices

Proteomic study purpose
Prediction or classification for clinical utility Association or classification for biologic insight Classification for novel subtype discovery
Example study BMD loss or hip fracture[57] Osteoclast biology[84] Colorectal cancer subtypes[85, 86]
Sample source Human population-at-risk Human biopsy, animal model, or cell line Human heterogeneous case mix
Sample type Easily accessible, like serum or plasma Biologically relevant, like bone tissue or osteoblasts Accessible during diagnosis, like through blood sample or biopsy
Analytic goal/approach Portable marker set to optimize prediction or classification Sufficient marker set to describe biologic process Portable marker set to optimally separate clinically meaningful classes
Proteomic technology Global and targeted Global Global and targeted